欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FI/H/0550/002
药品名称Mirtazapin Teva 30 mg
活性成分
    • mirtazapine 30.0 mg
剂型Orodispersible tablet
上市许可持有人TEVA Sweden AB Järnvägsgatan 11 BOX 1070 25110 HELSINGBORG
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Germany (DE)
      Mirtazapin_TEVA 30 mg Schmelztabletten
    • Denmark (DK)
    • Belgium (BE)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Mirtazapin TEVA 30 mg Schmelztabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Mirtazapin Teva
    • Norway (NO)
    • Lithuania (LT)
      Mirtazapine-Teva 30mg burnoje disperguojamosios tabletės
    • Hungary (HU)
      Mizapin Sol. tabletta
    • Czechia (CZ)
      MIRTAZAPINE – TEVA DisTab 30 mg
    • Slovakia (SK)
      Mitrtazapine-Teva DisTab30mg
许可日期2006/01/18
最近更新日期2018/11/14
药物ATC编码
    • N06AX11 mirtazapine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic [Article 10.1.(a)(iii), first paragraph]
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase